SCHEMBL5598601

SCHEMBL5598601

NCCCCC(NC(=O)C(Cc1c[nH]cn1)NC(=O)C(N)CO)C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SLC15A2 Q16348 1/20 0.49
ECE1 P42892 1/20 0.38
FOLH1 Q04609 1/20 0.38
ERAP2 Q6P179 3/20 0.37
LNPEP Q9UIQ6 3/20 0.37
GHSR Q92847 1/20 0.37
ERAP1 Q9NZ08 1/20 0.36
C5AR1 P21730 1/20 0.35
GNPAT O15228 1/20 0.35
CPB2 Q96IY4 2/20 0.35
NTSR2 O95665 1/20 0.35
NTSR1 P30989 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5598605 1.00 SLC15A2 (0.49) SLC15A2ECE1FOLH1ERAP2LNPEP
SCHEMBL4588801 0.99 SLC15A2 (0.48) SLC15A2ECE1FOLH1ERAP2LNPEP
SCHEMBL2813363 0.99 SLC15A2 (0.48) SLC15A2ECE1FOLH1ERAP2LNPEP
SCHEMBL31453801 0.94 SLC15A2 (0.51) SLC15A2ECE1FOLH1ERAP2LNPEP
SCHEMBL5884458 0.94 SLC15A2 (0.51) SLC15A2ECE1FOLH1ERAP2LNPEP
SCHEMBL29849009 0.94 SLC15A2 (0.51) SLC15A2ECE1FOLH1ERAP2LNPEP
SCHEMBL5884470 0.94 SLC15A2 (0.51) SLC15A2ECE1FOLH1ERAP2LNPEP
SCHEMBL29653641 0.93 SLC15A2 (0.50) SLC15A2ECE1FOLH1ERAP2LNPEP
SCHEMBL29653685 0.93 SLC15A2 (0.50) SLC15A2ECE1FOLH1ERAP2LNPEP
SCHEMBL29588307 0.92 SLC15A2 (0.47) SLC15A2ECE1FOLH1ERAP2LNPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026040002-A1 COMPOSITION AND METHOD FOR CARING FOR THE SKIN L'OREAL (FR) 2026-02-26 WO claimed
WO-2026040002-A1 COMPOSITION AND METHOD FOR CARING FOR THE SKIN L'OREAL (FR) 2026-02-26 WO disclosed
US-7186687-B2 Compositions and methods for treatment of Psoriasis PROCYTE CORPORATION (US) 2007-03-06 US disclosed